Position in NVS
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$143,862,698
+$21,531,199 QoQ
Shares Held
941,818
+6.1% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 29.4842527961878.ToString("F0")%
Shared 0.8788322159907753.ToString("F0")%
None 69.63691498782143.ToString("F0")%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Derivatives in NVS
reported options exposure · as of Dec 31, 2020CallValue
$236,075
CallShares
2,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026TRUIST FINANCIAL CORP holds $2,326,875,887 across 16 Drug Manufacturers - General names. NVS ranks #6 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
2,404,493 | $522,953,181 | |
| 2 | JNJ |
Johnson & Johnson
|
2,044,092 | $499,657,847 | |
| 3 | LLY |
ELI LILLY & Co
|
369,521 | $339,874,329 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,221,085 | $267,174,314 | |
| 5 | AZN |
Astrazeneca PLC
|
754,121 | $148,727,743 | |
| 6 | NVS |
Novartis AG
This page
|
941,818 | $143,862,698 | |
| 7 | AMGN |
Amgen Inc
|
407,214 | $143,278,245 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,272,131 | $77,154,744 |
All Filings in NVS
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $143,862,698 | 941,818 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $122,331,499 | 887,296 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $106,774,417 | 832,614 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $96,622,490 | 798,467 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $85,810,724 | 769,741 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $75,089,746 | 771,655 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $85,639,635 | 744,563 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $79,888,115 | 750,405 | Shares | Defined | 2024-08-21 | |
| 2024-03-31 | $73,133,875 | 756,062 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $83,841,952 | 830,365 | Shares | Defined | 2024-02-02 | |
| 2023-09-30 | $87,992,677 | 863,859 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $78,587,092 | 778,784 | Shares | Defined | 2023-08-01 | |
| 2023-03-31 | $76,490,272 | 831,416 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $86,708,269 | 955,779 | Shares | Defined | 2023-02-17 | |
| 2022-09-30 | $73,440,480 | 966,195 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $82,356,225 | 974,284 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $96,054,045 | 1,094,633 | Shares | Defined | 2022-04-22 | |
| 2021-12-31 | $89,079,446 | 1,018,400 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $84,663,642 | 1,035,261 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $91,225,218 | 999,838 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $82,807,467 | 968,735 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $236,075 | 2,500 | Call | Defined | 2021-11-19 | |
| 2020-12-31 | $84,253,842 | 892,236 | Shares | Defined | 2021-11-19 | |
| 2020-09-30 | $217,400 | 2,500 | Call | Defined | 2021-11-05 | |
| 2020-09-30 | $72,826,477 | 837,471 | Shares | Defined | 2021-11-05 | |
| 2020-06-30 | $218,350 | 2,500 | Call | Defined | 2021-11-16 | |
| 2020-06-30 | $72,557,877 | 830,752 | Shares | Defined | 2021-11-16 | |
| 2020-03-31 | $66,256,157 | 803,592 | Shares | Defined | 2021-11-05 | |
| 2020-03-31 | $206,125 | 2,500 | Call | Defined | 2021-11-05 | |
| No filing history on record for this holder in this stock. | ||||||